United States
Germany
Japan
United Kingdom
China
Products
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
Monkey IgA (Secretory component) goat polyclonal antibody, HRP
| Applications | Tested in immunoelectrophoresis and double radial immunodiffusion against a panel of appropriate secretions and purified immunoglobulin isotypes. In enzyme-immunocytochemical and immunohistochemical staining of free or bound secretory component at the cellular and subcellular level. In non-isotopic assay methodology (e.g. ELISA, Western blotting) in monkey milk or other secretions. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Recommended Working dilutions: Histochemical and cytochemical 1/150 - 1/500. ELISA and comparable non-precipitating antibody-binding assays 1/200 -1/4000. |
| Reactivities | Chimpanzee, Monkey |
| Conjugation | HRP |
Jagged1 (JAG1) (110-125) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Chimpanzee, Mouse, Rat |
Monkey IgA (Secretory component) goat polyclonal antibody, TRITC
| Applications | Tested in immunoelectrophoresis, double radial immunodiffusion and ELISA against a panel of appropriate secretions and purified Ig isotypes. Can be used as reagent for the direct detection of secretory component in monkey cells, tissues and body fluids in immunofluorescence; as detection reagent in non-isotopic methodology and solid phase immunochemistry (e.g. ELISA). This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1:10 and 1:40. |
| Reactivities | Chimpanzee, Monkey |
| Conjugation | TRITC |
Monkey IgA (Secretory component) goat polyclonal antibody, FITC
| Applications | Tested in immunoelectrophoresis, double radial immunodiffusion and ELISA against a panel of appropriate secretions and purified Ig isotypes. Can be used as reagent for the direct detection of secretory component in monkey cells, tissues and body fluids in immunofluorescence; as detection reagent in non-isotopic methodology and solid phase immunochemistry (e.g. ELISA). This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/20 and 1/80. |
| Reactivities | Chimpanzee, Monkey |
| Conjugation | FITC |
SIGLEC5 / SIGLEC14 mouse monoclonal antibody, clone 1A5, Purified
| Applications | ELISA, FC, IF, IP |
| Reactivities | Chimpanzee, Human |
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human, Chimpanzee, Goat, Sheep |
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human, Chimpanzee, Goat, Sheep |
EGR1 rabbit polyclonal antibody, Affinity purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Chimpanzee |
SAE1 rabbit polyclonal antibody, Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Bovine, Canine, Chimpanzee, Human, Mouse, Rat |
活动过滤器
clear Category
- Antibodies
优化搜索结果
Target Symbol
- HSPB1 (4)
- MYC (4)
- CD4 (3)
- SAE1 (3)
- ASAP1 (2)
- CD16 (2)
- CD81 (2)
- CDC27 (2)
- CDKN1A (2)
- DOPAMINE D2 RECEPTOR (2)
- EGR1 (2)
- GDF15 (2)
- GLG1 (2)
- ITGAM (2)
- MYB (2)
- ODF2 (2)
- PTPRC (2)
- SELL (2)
- SLC7A2 (2)
- TRIM29 (2)
- 5HT6 RECEPTOR (1)
- ADGRE5 (1)
- AE2 (1)
- AHA1 (1)
- AHSA1 (1)
- AKT1 (1)
- ALPHA ADAPTIN (1)
- ALPHA TUBULIN (1)
- AMYLOID PRECURSOR PROTEIN (1)
- ANKRD32 (1)
- AP3D1 (1)
- APE1 (1)
- ARHGEF11 (1)
- ASPARTATE AMINOTRANSFERASE (1)
- BETA ACTIN (1)
- BORIS (1)
- C-MYC (1)
- C5AR2 (1)
- CAMK4 (1)
- CASPASE 5 (1)
- CASZ1 (1)
- CD24 (1)
- CD59 (1)
- CENPU (1)
- CMTM6 (1)
- CYCLIN B1 (1)
- DMT1 (1)
- DNA PKCS (1)
- DOPAMINE RECEPTOR D3 (1)
- E2F1 (1)
- ECT2 (1)
- EIF3F (1)
- ENTPD2 (1)
- EPHA2 (1)
- ESTROGEN INDUCED GENE 121 PROTEIN (1)
- FANCA (1)
- FANCC (1)
- FANCF (1)
- FANCG (1)
- FBXO43 (1)
- FBXO9 (1)
- GGA3 (1)
- GLI2 (1)
- GLI3 (1)
- GPR4 (1)
- GPR48 (1)
- GZMB (1)
- HNRNPC (1)
- IL16 (1)
- INTERFERON GAMMA (1)
- JAG1 (1)
- KPNA2 (1)
- LDB2 (1)
- LIM KINASE 1 (1)
- MAGP2 (1)
- MDC1 (1)
- MTBP (1)
- MYOSIN 1G (1)
- NCAPH (1)
- NOTCH2 (1)
- NOXO1 (1)
- NR2E3 (1)
- OLFM4 (1)
- PARK7 (1)
- PGAM1 (1)
- PMS2 (1)
- PNK (1)
- POGZ (1)
- PROTEASOME SUBUNIT ALPHA TYPE 6 (1)
- RAB2 (1)
- RB2 P130 (1)
- RNF2 (1)
- SELENOPHOSPHATE SYNTHETASE 1 (1)
- SLC39A14 (1)
- SLC44A2 (1)
- SLC5A9 (1)
- SLIT3 (1)
- SPROUTY 4 (1)
- STAT2 (1)
- TA1 (1)
Antibody Hosts
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Families
- Druggable Genome (51)
- Transmembrane (25)
- Transcription Factors (9)
- GPCR (7)
- Stem cell - Pluripotency (6)
- ES Cell Differentiation/IPS (4)
- Protein Kinase (4)
- Secreted Protein (4)
- Embryonic stem cells (3)
- Adult stem cells (2)
- Cancer stem cells (2)
- Protease (2)
- Induced pluripotent stem cells (1)
- Ion Channels: Transient receptor potential (1)
- Nuclear Hormone Receptor (1)
- Phosphatase (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Pathways in cancer (6)
- Cell cycle (5)
- Jak-STAT signaling pathway (5)
- Neuroactive ligand-receptor interaction (5)
- Gap junction (4)
- Hedgehog signaling pathway (4)
- Metabolic pathways (4)
- Basal cell carcinoma (3)
- Chronic myeloid leukemia (3)
- Lysosome (3)
- Pathogenic Escherichia coli infection (3)
- Small cell lung cancer (3)
- TGF-beta signaling pathway (3)
- Acute myeloid leukemia (2)
- Bladder cancer (2)
- Cell adhesion molecules (CAMs) (2)
- Chemokine signaling pathway (2)
- Colorectal cancer (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Focal adhesion (2)
- Glioma (2)
- Glycolysis / Gluconeogenesis (2)
- MAPK signaling pathway (2)
- Melanoma (2)
- Non-small cell lung cancer (2)
- Oocyte meiosis (2)
- Pancreatic cancer (2)
- Progesterone-mediated oocyte maturation (2)
- Prostate cancer (2)
- Proteasome (2)
- Regulation of actin cytoskeleton (2)
- T cell receptor signaling pathway (2)
- Tight junction (2)
- Wnt signaling pathway (2)
- Adherens junction (1)
- Adipocytokine signaling pathway (1)
- Alanine (1)
- Allograft rejection (1)
- Alzheimer's disease (1)
- Apoptosis (1)
- Arginine and proline metabolism (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Axon guidance (1)
- B cell receptor signaling pathway (1)
- Base excision repair (1)
- Calcium signaling pathway (1)
- Cysteine and methionine metabolism (1)
- Cytokine-cytokine receptor interaction (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- Endocytosis (1)
- Fc epsilon RI signaling pathway (1)
- Fructose and mannose metabolism (1)
- Graft-versus-host disease (1)
- Huntington's disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Inositol phosphate metabolism (1)
- Insulin signaling pathway (1)
- Leukocyte transendothelial migration (1)
- Melanogenesis (1)
- Mismatch repair (1)
- NOD-like receptor signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- Neurotrophin signaling pathway (1)
- Non-homologous end-joining (1)
- Notch signaling pathway (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Prion diseases (1)
- Purine metabolism (1)
- Regulation of autophagy (1)
- Renal cell carcinoma (1)
- Selenoamino acid metabolism (1)
- Spliceosome (1)
- Systemic lupus erythematosus (1)
- Thyroid cancer (1)
- Toll-like receptor signaling pathway (1)
- Type I diabetes mellitus (1)
- Tyrosine metabolism (1)
- VEGF signaling pathway (1)
- Vibrio cholerae infection (1)
- Viral myocarditis (1)
- aspartate and glutamate metabolism (1)
- mTOR signaling pathway (1)
- p53 signaling pathway (1)
- tyrosine and tryptophan biosynthesis (1)
